Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19
Publication Date: June 28, 2023
Last Updated: June 30, 2023
Summary of Recommendations
In hospitalized patients with Coronavirus disease 2019 (COVID-19) who have a baseline indication to antiplatelet therapy due to a prior acute coronary syndrome (ACS), we suggest continuing antiplatelet therapy unchanged. (C, U)
Remark: Considerations on switching from ticagrelor or clopidogrel to prasugrel apply on a caseby-case basis if there are concerns for drug-drug interaction
2559259
Title
Antithrombotic Therapy in Arterial Thrombosis and Thromboembolism in COVID-19
Authoring Organization
American College of Chest Physicians